Harbor Investment Advisory’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-615
Closed -$49.9K 1305
2025
Q4
$49.9K Hold
615
﹤0.01% 666
2025
Q3
$53.8K Hold
615
﹤0.01% 628
2025
Q2
$51.1K Hold
615
﹤0.01% 632
2025
Q1
$51.6K Hold
615
0.01% 607
2024
Q4
$56.7K Sell
615
-187
-23% -$18K 0.01% 570
2024
Q3
$74.5K Hold
802
0.01% 522
2024
Q2
$66K Sell
802
-26
-3% -$1.91K 0.01% 528
2024
Q1
$54.9K Buy
828
+26
+3% +$1.6K 0.01% 566
2023
Q4
$45.5K Hold
802
0.01% 584
2023
Q3
$43.7K Hold
802
0.01% 572
2023
Q2
$54K Sell
802
-233
-23% -$14.2K 0.01% 683
2023
Q1
$53.3K Hold
1,035
0.01% 686
2022
Q4
$47.6K Sell
1,035
-26
-2% -$1.22K 0.01% 704
2022
Q3
$54K Hold
1,061
0.01% 663
2022
Q2
$48K Hold
1,061
0.01% 713
2022
Q1
$49K Hold
1,061
0.01% 756
2021
Q4
$53K Hold
1,061
0.01% 726
2021
Q3
$56K Buy
+1,061
New +$59.8K 0.01% 711

Other funds holding LMAT

Harbor Investment Advisory's LMAT Position: Q1 2026 in Review

Harbor Investment Advisory sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 615 shares — an estimated $49.9K sold.

Harbor Investment Advisory first reported a position in LMAT in Q3 2021 and held it in 18 quarters. The position peaked at $74.5K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Harbor Investment Advisory reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Harbor Investment Advisory sold 615 LeMaitre Vascular shares in Q1 2026, an estimated $49.9K.
  • Harbor Investment Advisory first reported a position in LeMaitre Vascular in Q3 2021 and held it in 18 quarters.
  • Harbor Investment Advisory's LeMaitre Vascular position peaked at $74.5K in Q3 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.